Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Effects of cannabinoids and related fatty acids upon the viability of P19 embryonal carcinoma cells.

Gustafsson SB, Wallenius A, Zackrisson H, Popova D, Plym Forshell L, Jacobsson SOP.

Arch Toxicol. 2013 Nov;87(11):1939-1951. doi: 10.1007/s00204-013-1051-3. Epub 2013 Apr 4.

PMID:
23552853
2.

Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil.

Gustafsson SB, Lindgren T, Jonsson M, Jacobsson SO.

Cancer Chemother Pharmacol. 2009 Mar;63(4):691-701. doi: 10.1007/s00280-008-0788-5. Epub 2008 Jul 16.

PMID:
18629502
3.

Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors.

Wagner JA, Járai Z, Bátkai S, Kunos G.

Eur J Pharmacol. 2001 Jul 6;423(2-3):203-10.

PMID:
11448486
4.
5.

Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2.

Olea-Herrero N, Vara D, Malagarie-Cazenave S, Díaz-Laviada I.

Br J Cancer. 2009 Sep 15;101(6):940-50. doi: 10.1038/sj.bjc.6605248. Epub 2009 Aug 18.

6.

Cytotoxicity of synthetic cannabinoids found in "Spice" products: the role of cannabinoid receptors and the caspase cascade in the NG 108-15 cell line.

Tomiyama K, Funada M.

Toxicol Lett. 2011 Nov 10;207(1):12-7. doi: 10.1016/j.toxlet.2011.08.021. Epub 2011 Sep 2.

PMID:
21907772
7.

The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.

Derocq JM, Bouaboula M, Marchand J, Rinaldi-Carmona M, Ségui M, Casellas P.

FEBS Lett. 1998 Apr 3;425(3):419-25.

8.

The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt.

Gómez del Pulgar T, Velasco G, Guzmán M.

Biochem J. 2000 Apr 15;347(Pt 2):369-73.

9.
10.

Cannabinoids.

Grotenhermen F.

Curr Drug Targets CNS Neurol Disord. 2005 Oct;4(5):507-30. Review.

PMID:
16266285
11.

Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways.

Gomez O, Sanchez-Rodriguez A, Le M, Sanchez-Caro C, Molina-Holgado F, Molina-Holgado E.

Br J Pharmacol. 2011 Aug;163(7):1520-32. doi: 10.1111/j.1476-5381.2011.01414.x.

12.

Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines.

Brown I, Cascio MG, Wahle KW, Smoum R, Mechoulam R, Ross RA, Pertwee RG, Heys SD.

Carcinogenesis. 2010 Sep;31(9):1584-91. doi: 10.1093/carcin/bgq151. Epub 2010 Jul 25.

14.

Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.

Di Marzo V, Melck D, Orlando P, Bisogno T, Zagoory O, Bifulco M, Vogel Z, De Petrocellis L.

Biochem J. 2001 Aug 15;358(Pt 1):249-55.

15.

Therapeutic potential of cannabinoids in CNS disease.

Croxford JL.

CNS Drugs. 2003;17(3):179-202. Review.

PMID:
12617697
16.

The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.

Luca T, Di Benedetto G, Scuderi MR, Palumbo M, Clementi S, Bernardini R, Cantarella G.

Eur J Pharmacol. 2009 Aug 15;616(1-3):16-21. doi: 10.1016/j.ejphar.2009.06.004. Epub 2009 Jun 17.

PMID:
19539619
17.

Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival.

Marcu JP, Christian RT, Lau D, Zielinski AJ, Horowitz MP, Lee J, Pakdel A, Allison J, Limbad C, Moore DH, Yount GL, Desprez PY, McAllister SD.

Mol Cancer Ther. 2010 Jan;9(1):180-9. doi: 10.1158/1535-7163.MCT-09-0407. Epub 2010 Jan 6.

18.

Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid.

Fowler CJ, Jonsson KO, Andersson A, Juntunen J, Järvinen T, Vandevoorde S, Lambert DM, Jerman JC, Smart D.

Biochem Pharmacol. 2003 Sep 1;66(5):757-67.

PMID:
12948856
19.

Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells.

Rajesh M, Mukhopadhyay P, Haskó G, Liaudet L, Mackie K, Pacher P.

Br J Pharmacol. 2010 Jun;160(3):688-700. doi: 10.1111/j.1476-5381.2010.00712.x.

20.

Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death.

Athanasiou A, Clarke AB, Turner AE, Kumaran NM, Vakilpour S, Smith PA, Bagiokou D, Bradshaw TD, Westwell AD, Fang L, Lobo DN, Constantinescu CS, Calabrese V, Loesch A, Alexander SP, Clothier RH, Kendall DA, Bates TE.

Biochem Biophys Res Commun. 2007 Dec 7;364(1):131-7. Epub 2007 Oct 2.

PMID:
17931597

Supplemental Content

Support Center